文献速递肝病

表达MerTK的肝脏巨噬细胞促进急性肝衰竭炎症消退

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.
PubMed 文献 · Gut · 2017-04-27

本研究探讨Mer酪氨酸激酶(MerTK)在急性肝衰竭(ALF)炎症消退中的作用及分泌性白细胞蛋白酶抑制剂(SLPI)的调控机制。在ALF患者循环和组织中观察到MerTK+HLA-DR高表达细胞显著扩增;APAP处理的Mer缺陷小鼠表现为持续性肝损伤和炎症,而SLPI在体外和体内均通过诱导MerTK+HLA-DR高表达表型重编程髓系细胞促进消退反应。

要点

  • ALF患者循环和组织中MerTK+HLA-DR高表达细胞显著扩增。
  • APAP处理的Mer缺陷小鼠表现为持续性肝损伤和炎症。
  • SLPI通过诱导MerTK+HLA-DR高表达表型促进中性粒细胞凋亡和清除。

核心结论

  • 鉴定出一种肝保护性MerTK+巨噬细胞表型,在ALF后消退阶段演化,是促进急性肝损伤后消退反应的新型免疫治疗靶点。

研究设计与样本

  • 采用流式细胞术、免疫组化、共聚焦成像和基因表达分析检测ALF患者、健康对照和疾病对照中MerTK+单核/巨噬细胞的表型、功能/转录组特征和组织分布。
  • 在APAP诱导的急性肝损伤中,使用野生型和Mer缺陷小鼠观察巨噬细胞MerTK表达的时间演变及其对消退的影响。
  • 在体外和APAP处理的野生型小鼠中确定SLPI对肝脏髓系细胞的作用。

主要发现

  • ALF患者循环和组织 compartments 中消退样MerTK+HLA-DR高表达细胞显著扩增。
  • 与消退期MerTK+MHCII高表达巨噬细胞增加的野生型小鼠相比,APAP处理的Mer缺陷小鼠表现为持续性肝损伤和炎症,以驻留Kupffer细胞比例降低和中性粒细胞数量增加为特征。
  • 体外和APAP处理小鼠中,SLPI通过诱导MerTK+HLA-DR高表达表型重编程髓系细胞向消退反应,促进中性粒细胞凋亡及其后续清除。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Acute liver failure (ALF) is characterised by overwhelming hepatocyte death and liver inflammation with massive infiltration of myeloid cells in necrotic areas. The mechanisms underlying resolution of acute hepatic inflammation are largely unknown. Here, we aimed to investigate the impact of Mer tyrosine kinase (MerTK) during ALF and also examine how the microenvironmental mediator, secretory leucocyte protease inhibitor (SLPI), governs this response. DESIGN: Flow cytometry, immunohistochemistry, confocal imaging and gene expression analyses determined the phenotype, functional/transcriptomic profile and tissue topography of MerTK+ monocytes/macrophages in ALF, healthy and disease controls. The temporal evolution of macrophage MerTK expression and its impact on resolution was examined in APAP-induced acute liver injury using wild-type (WT) and Mer-deficient (Mer-/-) mice. SLPI effects on hepatic myeloid cells were determined in vitro and in vivo using APAP-treated WT mice. RESULTS: We demonstrate a significant expansion of resolution-like MerTK+HLA-DRhigh cells in circulatory and tissue compartments of patients with ALF. Compared with WT mice which show an increase of MerTK+MHCIIhigh macrophages during the resolution phase in ALF, APAP-treated Mer-/- mice exhibit persistent liver injury and inflammation, characterised by a decreased proportion of resident Kupffer cells and increased number of neutrophils. Both in vitro and in APAP-treated mice, SLPI reprogrammes myeloid cells towards resolution responses through induction of a MerTK+HLA-DRhigh phenotype which promotes neutrophil apoptosis and their subsequent clearance. CONCLUSIONS: We identify a hepatoprotective, MerTK+, macrophage phenotype that evolves during the resolution phase following ALF and represents a novel immunotherapeutic target to promote resolution responses following acute liver injury.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Triantafyllou E, Pop OT, Possamai LA, et al. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut. 2017. PMID: 28450389. doi:10.1136/gutjnl-2016-313615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。